Recruiting Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373 Conditions Adenocarcinoma, Adnexal Diseases, Advanced Breast Carcinoma, +110 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
